From the ∗Division of Urogynecology
†Department of Internal Medicine, Mayo Clinic
‡Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic Center for Regenerative Medicine
§Department of Radiology
∥Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Correspondence: Cassandra K. Kisby, MD, MS. E-mail: [email protected].
This article was published online ahead of print on January 11, 2021.
E.T. received royalties from Elsevier and UpToDate; A.B. is the cofounder of RION LLC. The other authors have declared they have no conflicts of interest.
This publication was made possible by CTSA grant UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. The authors also received support from the Shannon Family Philanthropic Grant and a Mayo Clinic Obstetrics and Gynecology Small Grant. Sponsors did not participate in study design or manuscript preparation.
Data in this manuscript were presented at the American Urogynecologic Society/International Urogynecological Association Joint Scientific Meeting in September 24–28, 2019 (Nashville, TN).
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.fpmrs.net).